Master Market Swings: Tickeron's Top Robot Surpasses S&P 500 Gains 2X! Your Key to Navigating Volatility with Precision.
The Tickeron quant team is excited to introduce our premier AI robot, specifically optimized for Swing Traders. This tool represents the pinnacle of our technological advancements in trading algorithms. Excelling in the market, it has achieved an impressive feat, earning twice as much as the S&P 500 in just the past week. This robot, capable of handling 20-30 trades with an average duration of 1 day, comes equipped with a risk management strategy adaptable to your trading balance. It smartly selects stocks with varying volatility and utilizes an advanced algorithmic approach for trade entry and exit, ensuring optimal performance and profitability.
Swing Trader ($6K per position): Volatility Balanced Strategy v.2 (TA)
Click to view full description and closed trades for free!
This is how this robot works.
Operational Mechanics
- Our algorithms kick off by analyzing short and medium-term trends for each stock.
- We then use a unique set of technical indicators to pinpoint the perfect moment for trade initiation.
- Finally, the algorithm adjusts the position size based on the identified trends' volatility and direction.
Trade Execution and Exit Strategies
With strategies like a fixed 3% stop-loss and a flexible trailing stop, the robot optimizes profit retention, adapting to market reversals.
Transparent Results and In-Depth Analysis
Experience real-time insights into the robot's operations without margin use. For detailed statistics and an equity chart, explore further on our robot page.
Here are the latest trades:
FCEL's RSI Oscillator ascends from oversold territory
The RSI Oscillator for FCEL moved out of oversold territory on April 24, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 41 similar instances when the indicator left oversold territory. In of the 41 cases the stock moved higher. This puts the odds of a move higher at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where FCEL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on May 06, 2025. You may want to consider a long position or call options on FCEL as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for FCEL just turned positive on April 14, 2025. Looking at past instances where FCEL's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where FCEL advanced for three days, in of 239 cases, the price rose further within the following month. The odds of a continued upward trend are .
FCEL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FCEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for FCEL entered a downward trend on May 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.817) is normal, around the industry mean (3.974). P/E Ratio (0.000) is within average values for comparable stocks, (40.775). FCEL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.638). Dividend Yield (0.000) settles around the average of (0.096) among similar stocks. P/S Ratio (5.023) is also within normal values, averaging (140.515).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. FCEL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a manufacturer of pharmaceuticals products
Industry PharmaceuticalsMajor